Oncology & Hematology Market Reports

Cancer diagnosis and treatment represents a significant expenditure in developed healthcare systems. Cancer screening is performed through routine tests such as complete blood counts (CBCs), differentials, and protein markers. However, the global oncology diagnostics market is quickly evolving past established markers and companion diagnostics in the United States, Europe and Japan. Targeted cancer therapies are finding significant demand in emerging middle-income countries such as China and new technologies such as liquid biopsies, next-generation sequencing (NGS) and novel hybridization assays are being developed for cancer detection and diagnosis. Kalorama Information market research covers cancer diagnostics from multiple angles of diagnostic technology and regional demand.

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: Apr 24, 2017 | Price: $250.00
A look at key trends in in vitro diagnostics in the month of April 2017....
Published: Mar 22, 2017 | Price: $250.00
Kalorama's current trends in the in vitro diagnostic industry.  ...
Published: Mar 24, 2016 | Price: $2,500.00
Cancer Markers Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays - tumor markers, flow cytometry,...
Published: Jan 22, 2016 | Price: $4,500.00
This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics,...
Published: Jan 6, 2016 | Price: $4,200.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical...
Published: Oct 26, 2015 | Price: $499.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals...
Published: Oct 26, 2015 | Price: $0.00
A brief look at commercialized testing services for cancer diagnostics.  For more detailed information, Kalorama Information offers The World Market for Cancer Diagnostics....
Published: Sep 11, 2015 | Price: $1,995.00
The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays)Cancer testing is maturing from personalized medicine to precision...
Published: Nov 20, 2014 | Price: $995.00
Histology and cytology tests are essential for identifying cancer, inherited, infectious disease and other diseases.  This report focuses on tissue and cell diagnostic assays and technologies, providing the world markets for histology and cytology diagnostics for the current market and forecasted...
Published: Oct 30, 2014 | Price: $995.00
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing) Kalorama Information’s report on Women's Health Diagnostic Markets takes a solid look at the current and developing world...
Published: Jun 16, 2014 | Price: $995.00
The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications...
Published: Mar 18, 2014 | Price: $1,995.00
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market.  Most recently the U.S. IVD...
Published: Dec 16, 2013 | Price: $995.00
Full coverage of the IVD market in Mexico, including important IVD segments.  ...
Published: Nov 22, 2013 | Price: $1,995.00
The World Market for HematologyUsed for both critical and routine testing, hematology is a central part of IVD.   CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin...
Published: Oct 25, 2013 | Price: $1,995.00
What is the procedure, for establishing reimbursement for an IVD test product?  What companies have been successful and how?  What changes will IVD makers face in the near-term.  This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions...
Published: May 8, 2013 | Price: $2,995.00
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early...
Published: Jan 31, 2013 | Price: $1,995.00
IVD Procedure Volume and Pricing Analysis This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes.. Point of Care (Glucose, Pregnancy,...
Published: Jan 9, 2013 | Price: $4,500.00
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip.  This...
Published: Aug 15, 2012 | Price: $995.00
Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever.  Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of...
Published: Jul 27, 2012 | Price: $995.00
In eight best-selling editions, Shara Rosen has detailed the market for in vitro diagnostic (IVD) testing, throughout the world,  in one complete volume. The report, The Worldwide Market for In Vitro Diagnostic Tests, is a testament to the Kalorama methodology. Real industry knowledge combined...
Published: Jan 1, 2012 | Price: $1,995.00
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology...
Published: Mar 1, 2011 | Price: $300.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows...
Published: Jun 1, 2010 | Price: $4,995.00
NOTE: This report is based on 2008 Market Data The current population of India is 1.14 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a...
Published: Apr 1, 2010 | Price: $4,200.00
Since Kalorama Information last updated our comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of service products , PGx testing and tissue microarrays are showing an increased presence. Some...
Published: Nov 1, 2009 | Price: $3,995.00
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.